Synthes Acis/Vertebral Spacer Cr
510(k) K120275
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK120275 | Date25 May 2012 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- ODP
- FDA applicant
- Synthes (Usa), LLC
- Device Class
- Class II
- Regulation
- 21 CFR Part 888.3080
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 22 Sep 2026
The Synthes ACIS and Vertebral Spacer CR are radiolucent cervical intervertebral body fusion devices. These implants are designed to be inserted within the intervertebral disc space to provide structural stability in skeletally mature individuals with degenerative disc disease.
The devices are implanted via an anterior approach and are intended to be used with supplemental fixation. The interior of the spacer is packed with autogenous bone graft to facilitate fusion. This device has received FDA 510(k) clearance.
Other devices from Synthes (Usa)
Questions
AI-generated answers, 22 Sep 2026
What is the intended use of the Synthes ACIS/Vertebral Spacer CR?
This device is a radiolucent cervical intervertebral body fusion implant designed to provide structural stability within the intervertebral disc space for skeletally mature individuals diagnosed with degenerative disc disease.
How is the Synthes ACIS/Vertebral Spacer CR implanted?
The device is implanted using an anterior surgical approach. It is intended to be used in conjunction with supplemental fixation to ensure proper stability during the fusion process.
How is the fusion process supported by this device?
To facilitate the fusion process, the interior of the spacer is designed to be packed with autogenous bone graft, which encourages bone growth and structural integration within the disc space.
What is the regulatory status of this device?
The Synthes ACIS and Vertebral Spacer CR has received FDA 510(k) clearance, which indicates that the device has been determined to be substantially equivalent to legally marketed predicate devices.